Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1464-410x.1992.tb15715.x | DOI Listing |
Urology
November 2024
Mayo Clinic Department of Urology, Rochester, MN. Electronic address:
Objective: To characterize and identify factors associated with long-term morbidity of definitive urosymphyseal fistula (USF) treatment.
Methods: Retrospective chart review of a single institution database identified 57 patients who underwent operative treatment of USF between 2009 and 2022 with at least 90 days of follow-up. Delayed complications were considered those occurring ≥90 days following surgery.
Cancer Rep (Hoboken)
November 2024
Division of Gynecologic Oncology, Michele and Pietro Ferrero Hospital, Verduno, Italy.
Mil Med Res
October 2024
Department of Urology, University College Hospital of London, London, NW1 2BU, UK.
Cancers (Basel)
September 2024
Department of Urology, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041 Madrid, Spain.
Objective: To assess the survival outcomes of patients diagnosed with muscle-invasive bladder cancer (MIBC) who are not candidates for curative treatment and to identify the factors influencing these outcomes.
Methods: We conducted an analysis of patients diagnosed with MIBC who were either unable or unwilling to undergo curative therapy. We evaluated overall survival (OS) and cancer-specific survival (CSS) and examined their associations with various clinical variables.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!